Exact Sciences Launches Oncodetect Test
Exact Sciences has launched Oncodetect, a new test designed to detect molecular residual disease (MRD) across multiple solid tumors, the company announced today. “Exact Sciences is transforming cancer care by…
Category Archives: Biotech
Promega’s Tech to Aid Global Vaccine Research
Promega’s HiBiT-PsVLP Bioassay will be used in the development of vaccines for infectious viral diseases and help support a collaboration between Charles River and the Coalition for Epidemic Preparedness Innovations’…
SHINE Partners with Sumitomo to Access Asia
SHINE Technologies is partnering with Sumitomo Corporation of Americas (SCOA), a leading global trading and investment company, the company announced today. According to a release, the partnership, formalized through a…
The Week Ahead April 7, 2025
Presentations, Pitches 4-5:30 p.m. Tuesday, April 8 at Elvehjem Building – UW Madison School of Computer, Data & Information Sciences: RED Talks: Virtually Unwrapping the Herculaneum Scrolls 6-8 p.m. Tuesday,…
Exact Sciences Launches Cologuard Plus Test
Exact Sciences has launched Cologuard Plus, a next-generation, noninvasive colorectal cancer screening text, the company announced today. According to a release, the Cologuard Plus test detects 95% of colorectal cancers…
Exact Sciences, Flatiron Health to Partner
Exact Sciences and Flatiron Health, a healthtech company dedicated to improving cancer care and advancing research, are partnering to accelerate clinical evidence generation for Exact Sciences’ molecular residual disease test…
Invenra, Orion Enter Research Collaboration
Invenra and Orion Corporation, a globally operating pharmaceutical company, announced recently that they have entered into a research collaboration to discover bispecific antibodies using Invenra’s B-Body platform. “This collaboration highlights…
SHINE to Supply UK Organization
SHINE Technologies has been selected to provide a 14 mega electron volt deuterium-tritium fusion system to the U.K. Atomic Energy Authority (UKAEA)’s Lithium Breeding Tritium Innovation (LIBRTI) program in 2027,…
SHINE, Antelope Surgical Solutions to Partner
SHINE Technologies has partnered with Antelope Surgical Solutions, a biotech company pioneering next-generation multimodal radiopharmaceuticals, the company announced recently. According to a release, the supply agreement will accelerate Antelope’s clinical…
SHINE, Primo Biotech to Partner
SHINE Technologies is partnering with Primo Biotechnology, a developer of high-precision radiopharmaceuticals, the company announced today. According to a release, the agreement grants Primo exclusive distribution rights for SHINE’s Ilumira…
